1) Findings: Insights and developments globally on the subject of cancer.
2) Companies: Updates and progress reports on Consortium member companies.
3) Industry: Important developments from throughout the field of cancer.
Scientists may have pinpointed the cause of some forms of a rare cancer called gastrointestinal stromal tumors (GISTs), according to a new NCI-funded study. However, the culprit isn’t a harmful genetic mutation, as is typical for […]
For some patients with an aggressive form of metastatic colorectal cancer, a treatment regimen that consists of a combination of targeted cancer drugs can improve how long they live without increasing their risk […]
Pancreatic cancer is a particularly vicious disease. Because the pancreas is nestled deep within the internal organ cavity, identifying the tumor early is a rare occurrence. In fact, over half of the […]
Scientists have developed a noninvasive device that may not only detect melanoma cells traveling through the bloodstream, but also kill them. The device, which the investigators call Cytophone, accurately detected cancer cells in 27 […]
ELAA Technology, an Istanbul-based company, has developed a software application which is used in conjunction with a bronchoscopy unit. By providing a patient’s Computerized Tomography (CT) images and bronchoscopy camera feed, it […]
People must eat to survive. And the cells that make up the body eat too. Or more accurately, cells break down and rebuild food into the individual molecules they need to stay […]
Researchers have launched a clinical trial to test an immunotherapy drug in patients who have both cancer and an autoimmune disease, such as rheumatoid arthritis, lupus, or multiple sclerosis. Immunotherapy drugs enhance the ability of the […]
In April, the drug erdafitinib (Balversa) became the first therapy targeting a genetic alteration to be approved by the Food and Drug Administration (FDA) to treat patients with metastatic urothelial carcinoma, the most common type of bladder […]
